Poorer prognosis observed for lung adenocarcinoma patients with higher FOXH1 expression in tumor implies FOXH1 is a prognosis marker and can be a potential treatment target for lung cancer. The gene discussed is FOXH1; the disease is lung adenocarcinoma.